Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”

Calcitonin testing in patients with thyroid nodules for screening medullary thyroid carcinoma: a “gray zone”

Introduction. The results of the calcitonin (Ctn) study in patients with thyroid nodules are included in the clinical guidelines for the treatment of differentiated thyroid cancer. However, the management of patients with moderately elevated Ctn up to 100 pg/mL is not clearly defined.Materials and m...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. V. Severskaya, A. A. Ilyin, I. V. Chebotareva, N. V. Zhelonkina, P. A. Isaev, V. V. Polkin, S. A. Ivanov, A. D. Kaprin
Format:	Article
Language:	Russian
Published:	ABV-press 2022-08-01
Series:	Опухоли головы и шеи
Subjects:	calcitonin cancer embryonic antigen medullary thyroid carcinoma screening <i>ret</i>
Online Access:	https://ogsh.abvpress.ru/jour/article/view/780
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SPORADIC MEDULLARY THYROID CANCER. СASE REPORT
by: L. A. Ivanova, et al.
Published: (2015-04-01)

Measurement of calcitonin and cea in the needle washout fluid from thyroid nodule for the diagnosis of medullary thyroid carcinoma
by: N. V. Severskaya, et al.
Published: (2023-11-01)

Selpercatinib in the treatment of medullary and radioiodine-refractory differentiated thyroid cancer with RET mutation (literature review)
by: E. V. Borodavina, et al.
Published: (2025-03-01)

Selpercatinib – a new option for a precision approach to the treatment of medullary thyroid cancer
by: A. K. Plugar, et al.
Published: (2024-12-01)

Overview of management and therapeutic advances in medullary thyroid cancer
by: Mark A Jara, et al.
Published: (2025-03-01)

Changing the paradigm: lobectomy for sporadic medullary thyroid cancer
by: Marina Lugaresi, et al.
Published: (2025-04-01)

MEDULLARY THYROID CARCINOMA
by: V. S. Medvedev, et al.
Published: (2015-04-01)

Medullary thyroid cancer in combination with autoimmune thyroiditis after COVID-19
by: E. V. Ryabchenko
Published: (2022-06-01)

Breast metastasis from medullary thyroid carcinoma: a report of a case
by: Yoko Omi, et al.
Published: (2021-08-01)

Medullary thyroid carcinoma in a 6-year-old boy with previous Langerhans cell histiocytosis presenting high level of pro-calcitonin
by: Gerdi Tuli, et al.
Published: (2025-01-01)

Comparing the Diagnostic Efficacy of Different Calcitonin Stimulation Tests for Sporadic Medullary Thyroid Carcinoma: Calcium Gluconate vs. Calcium Chloride
by: Jovan Ilic, et al.
Published: (2025-07-01)

MEDULLARY THYROID CANCER AS PART OF MEN 2B SYNDROME. CASE REPORT
by: L. N. Lyubchenko, et al.
Published: (2015-04-01)

Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment
by: Sirmen Kızılcan Çetin, et al.
Published: (2025-09-01)

Next-Generation Sequencing Reveals the Potential Role of RET Protooncogene in Metastasis Progression in Medullary Thyroid Cancer
by: Maurice Klein, et al.
Published: (2025-07-01)

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
by: Sena Turkdogan, et al.
Published: (2018-09-01)

Efficacy of external beam radiotherapy and targeted therapy with vandenanib in patients with inoperable and progressive medullary thyroid cancer
by: A. D. Kaprin, et al.
Published: (2018-11-01)

Acute severe hypocalcaemia after initiation of a selective RET-inhibitor in medullary thyroid cancer
by: Leslie Cheng, et al.
Published: (2025-02-01)

A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer
by: Tariq Alqahtani, et al.
Published: (2024-12-01)

A Bibliometric Analysis of Medullary Thyroid Carcinoma From 2000 to 2022
by: TAN Meijuan, et al.
Published: (2024-07-01)

A Comparative Study on the Multidimensional Features of Hereditary and Sporadic Medullary Thyroid Carcinoma Patients: A Single-Center Retrospective Study
by: Muzaffer Serdar Deniz, et al.
Published: (2025-06-01)

Characteristics of gene mutations in Vietnamese medullary thyroid carcinoma patients: a single-center analysis
by: Van Hung Pham, et al.
Published: (2025-03-01)

Possibilities of single photon emission tomography in the diagnosis of bone metastases in patients with disseminated medullary thyroid carcinoma (case report)
by: E. E. Stanyakina, et al.
Published: (2019-07-01)

Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations
by: Özlem Boybeyi-Türer, et al.
Published: (2016-08-01)

THE DIAGNOSIS AND TREATMENT OF MEDULLARY THYROID CANCER
by: V. Zh. Brzhezovsky, et al.
Published: (2015-04-01)

CURRENT CAPABILITIES AND PROSPECTS OF CHEMORADIOTHERAPY FOR MEDULLARY THYROID CANCER (A LITERATURE REVIEW)
by: I. S. Pimonova, et al.
Published: (2017-11-01)

Role of the calcium stimulation test in diagnosing medullary thyroid cancer: is it adequate to achieve a diagnosis in both sexes? An individual patient data meta-analysis
by: Franz Sesti, et al.
Published: (2025-05-01)

Complexities in diagnosis and treatment of medullary thyroid cancer. Clinical observation
by: E. V. Frolova, et al.
Published: (2024-10-01)

Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients
by: Guenda Di Benedetto, et al.
Published: (2025-01-01)

Disseminated medullary thyroid carcinoma. Optimal approach to treatment
by: I. S. Romanov, et al.
Published: (2019-01-01)

A Unique Case of Medullary Thyroid Carcinoma in the Background of Hashimoto's Thyroiditis
by: Allahdad Khan, et al.
Published: (2025-04-01)

Thyroglobulin measurement in the needle washout for diagnosis of lymph node metastases of differentiated thyroid cancer
by: N. V. Severskaya, et al.
Published: (2023-06-01)

Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report
by: А. М. Mudunov, et al.
Published: (2019-10-01)

Surgical treatment of a patient with multiple endocrine neoplasia type 2A
by: T. A. Britvin, et al.
Published: (2020-11-01)

Optimization of [18F]-DOPA PET/CT Protocol in Patients with Medullary Thyroid Carcinoma: a Prospective Study
by: N. V. Tsentr, et al.
Published: (2025-03-01)

Simultaneous presentation of parathyroid adenoma and papillary and medullary thyroid carcinoma
by: Luis R. Albavera-Giles, et al.
Published: (2025-04-01)

Clinicopathological features and outcomes in patients with concurrent medullary and papillary thyroid carcinoma
by: Ruonan Sun, et al.
Published: (2025-08-01)

Ultrasonographic differentiation of medullary thyroid carcinoma from papillary thyroid carcinoma: quantitative comparison of morphologic features and different TIRADS risk categorizations
by: Xiaoyu Li, et al.
Published: (2025-05-01)

Use of selpercatinib in a patient with <i>RET</i>-mutated non-small cell lung cancer: case report
by: A. M. Kazakov, et al.
Published: (2024-05-01)

Medullary Thyroid Carcinoma Detected by Routine Health Screening Had Better Clinical Outcome and Survival
by: Ji Hyun Yoo, et al.
Published: (2025-06-01)

A Case of Medullary Carcinoma of the Jejunum Combined with the Intestinal Lymphangiectasia Accompanied by the Malabsorption Syndrome
by: O. A. Lobanova, et al.
Published: (2023-11-01)